Journal of Surgery

Stephen F. Amato

Stephen F. Amato
Senior Faculty Member, Biomedical Regulatory Affairs Program, College of Professional Studies
Northeastern University, USA

Biography

Dr. Stephen F. Amato has over 20 years of experience in the pharmaceutical, biotechnology and medical device industries.  He is a Senior Faculty Member of the Biomedical Regulatory Affairs Program in the College of Professional Studies at Northeastern University.  Steve is also the Managing Director of tJun 17 Life Sciences, LLC, an organization that facilitates the global commercialization of early stage medical technologies.  Prior to founding tJun 17 Life Sciences, Steve was an Executive Director at Anika Therapeutics where he served as the Head of Anikas Marketing Department.  In this role he managed all aspects of the companys product portfolio including market segmentation, targeting, positioning, pricing and promotional strategies.  From 2000 to 2007 he was the Group Director of Knee Repair at Smith & Nephew Endoscopy where he managed a $140 M orthopedic product portfolio.   Earlier in his career, Steve worked for Visible Genetics, where he was responsible for developing and launching genomic molecular diagnostics products used for subtyping Human Papilloma Virus (HPV) and other infectious disease agents.  He has also worked with Critical Therapeutics on the development and commercialization of treatments for gram-negative sepsis.
Dr. Amato holds an AB in Biochemical Sciences from Harvard University, a Ph.D. in Molecular and Cellular Biology from Boston College’s Graduate School of Arts & Sciences, and an MBA from the Carroll School of Graduate Management at Boston College.  He has received the US Regulatory Affairs Certification (RAC) designation and is a Consultant for the Regulatory Affairs Professional Society (RAPS).

Research Interest

Visible Genetics, Genomic Molecular Diagnostics Products, Critical Therapeutics, Molecular and Cellular Biology, Regulatory Affairs